Nanjing Vazyme Biotech Co Ltd
SSE:688105
Nanjing Vazyme Biotech Co Ltd
Depreciation & Amortization
Nanjing Vazyme Biotech Co Ltd
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
N
|
Nanjing Vazyme Biotech Co Ltd
SSE:688105
|
Depreciation & Amortization
-¥88.8m
|
CAGR 3-Years
-97%
|
CAGR 5-Years
-97%
|
CAGR 10-Years
N/A
|
Beigene Ltd
HKEX:6160
|
Depreciation & Amortization
-¥363.1m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-65%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Depreciation & Amortization
-¥186.6m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Depreciation & Amortization
-¥23.7m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-76%
|
CAGR 10-Years
N/A
|
See Also
What is Nanjing Vazyme Biotech Co Ltd's Depreciation & Amortization?
Depreciation & Amortization
-88.8m
CNY
Based on the financial report for Dec 31, 2023, Nanjing Vazyme Biotech Co Ltd's Depreciation & Amortization amounts to -88.8m CNY.
What is Nanjing Vazyme Biotech Co Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-97%
Over the last year, the Depreciation & Amortization growth was -140%. The average annual Depreciation & Amortization growth rates for Nanjing Vazyme Biotech Co Ltd have been -97% over the past three years , -97% over the past five years .